Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-25 @ 2:23 AM
NCT ID:
NCT07202234
Eligibility Criteria:
Inclusion Criteria:
1. Diagnosed with ventilator-associated pneumonia (VAP);
2. Identified infection with MDR Klebsiella pneumoniae, Acinetobacter baumannii, or Pseudomonas aeruginosa via MROSE evaluation and antimicrobial susceptibility testing (AST) from this or other tertiary hospitals;
3. Aged 18 to 85 years;
4. Written informed consent obtained from the patient or legal guardian.
Exclusion Criteria:
1. Pregnant or breastfeeding women;
2. FiO₂ ≥ 70% or PEEP ≥ 15 cmH₂O;
3. Hemodynamic instability (vasopressor dose increased by ≥30% in the last 6 hours or norepinephrine \> 0.5 μg/kg/min);
4. Known allergy to phage components.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT07202234
Study Brief:
Protocol Section:
NCT07202234